Literature DB >> 20001795

Updated lung cancer staging system.

Ramon Rami-Porta1, Kari Chansky, Peter Goldstraw.   

Abstract

The tumor, node and metastasis classification of malignant tumors is periodically revised. Its seventh edition includes the updated classification for lung cancer, based on the analyses of the International Association for the Study of Lung Cancer international database. It is the largest validation ever carried out to date: 100,869 patients registered in 46 databases from 20 countries. The analysis of this database allowed a detailed study of the impact of tumor size on prognosis, the reclassification of additional tumor nodules, the reclassification of pleural dissemination and the separation of two groups of metastatic disease. These changes led to modifications in stage grouping that better differentiate tumors with different prognosis. This updated classification is also recommended for small-cell lung cancer, and for broncho-pulmonary carcinoids. A new international nodal map with stations and zones, and a histological definition of visceral pleura invasion, have also been proposed.

Entities:  

Mesh:

Year:  2009        PMID: 20001795     DOI: 10.2217/fon.09.131

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


  7 in total

1.  Down-regulation of miR-452 is associated with poor prognosis in the non-small-cell lung cancer.

Authors:  Zhicheng He; Yang Xia; Bin Liu; Xiaotong Qi; Zhi Li; Jun Wang; Liang Chen; Yijiang Chen
Journal:  J Thorac Dis       Date:  2016-05       Impact factor: 2.895

2.  A phase II first-line study of gemcitabine, carboplatin, and bevacizumab in advanced stage nonsquamous non-small cell lung cancer.

Authors:  Christelle Clément-Duchêne; Yelena Krupitskaya; Kristen Ganjoo; Philip Lavori; Alex McMillan; Atul Kumar; Gary Zhao; Sukhmani Padda; Lisa Zhou; Melanie San Pedro-Salcedo; A Dimitrios Colevas; Heather A Wakelee
Journal:  J Thorac Oncol       Date:  2010-11       Impact factor: 15.609

3.  Predicting the prognosis of lung cancer: the evolution of tumor, node and metastasis in the molecular age-challenges and opportunities.

Authors:  Ramón Rami-Porta; Hisao Asamura; Peter Goldstraw
Journal:  Transl Lung Cancer Res       Date:  2015-08

4.  Metagenes associated with survival in non-small cell lung cancer.

Authors:  Egon Urgard; Tõnu Vooder; Urmo Võsa; Kristjan Välk; Mingming Liu; Cheng Luo; Fabian Hoti; Retlav Roosipuu; Tarmo Annilo; Jukka Laine; Christopher M Frenz; Liqing Zhang; Andres Metspalu
Journal:  Cancer Inform       Date:  2011-06-02

5.  Stage and tissue-specific prognostic impact of miR-182 in NSCLC.

Authors:  Helge Stenvold; Tom Donnem; Sigve Andersen; Samer Al-Saad; Lill-Tove Busund; Roy M Bremnes
Journal:  BMC Cancer       Date:  2014-02-27       Impact factor: 4.430

6.  High tumor cell expression of microRNA-21 in node positive non-small cell lung cancer predicts a favorable clinical outcome.

Authors:  Helge Stenvold; Tom Donnem; Sigve Andersen; Samer Al-Saad; Andrej Valkov; Mona Irene Pedersen; Lill-Tove Busund; Roy M Bremnes
Journal:  BMC Clin Pathol       Date:  2014-02-13

7.  CD45RO(+) Memory T Lymphocytes--a Candidate Marker for TNM-Immunoscore in Squamous Non-Small Cell Lung Cancer.

Authors:  Erna-Elise Paulsen; Thomas Kilvaer; Mehrdad Rakaee Khanehkenari; Ramona Johansen Maurseth; Samer Al-Saad; Sigurd M Hald; Khalid Al-Shibli; Sigve Andersen; Elin Richardsen; Lill-Tove Busund; Roy Bremnes; Tom Donnem
Journal:  Neoplasia       Date:  2015-11       Impact factor: 5.715

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.